{"id":502102,"date":"2020-08-13T15:14:01","date_gmt":"2020-08-13T15:14:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=502102"},"modified":"2020-08-13T15:14:01","modified_gmt":"2020-08-13T15:14:01","slug":"covid-19-impact-analysis-preclinical-imaging-market-trends-2020-global-size-industry-growth-share-regional-revenue-top-company-profile","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/covid-19-impact-analysis-preclinical-imaging-market-trends-2020-global-size-industry-growth-share-regional-revenue-top-company-profile_502102.html","title":{"rendered":"COVID 19 Impact Analysis: Preclinical Imaging Market Trends 2020, Global Size, Industry Growth, Share, Regional Revenue, Top Company Profile"},"content":{"rendered":"
\"COVID<\/a><\/p>\n
\n
Preclinical Imaging Market<\/div>\n<\/div>\n<\/div>\n
Preclinical Imaging Market Research Report: by Product (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging System), by Reagent (Optical, Nuclear, CT Contrast Agents, MRI Contrast Agents) – Global Forecast Till 2023<\/div>\n

Preclinical Imaging Market <\/strong>Scenario<\/strong><\/p>\n

As per the MRFR report, the global preclinical imaging market 2020 is anticipated to grow exponentially over the prognosis period. The market is predicted to secure revenue generation past its last recorded value of USD 2.01 billion in 2017 at a CAGR of 6.3%.<\/p>\n

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https:\/\/www.marketresearchfuture.com\/sample_request\/7365<\/a><\/strong><\/p>\n

Preclinical Imaging Market <\/strong>highlights<\/strong><\/p>\n

Factors such as developments in molecular imaging technologies, growing consumer interest for non-invasive small-animal imaging approaches, and growing R&D investments to support preclinical research are slated to propel market growth. Preclinical micro-ultrasound technologies are being investigated for developmental genetics, cancer , and cardiovascular disease. The new advances in high-frequency ultrasonic imaging are still being established with respect to the future. The use of multiple imaging modalities for preclinical trials will help researchers understand the biological, genetic, and physiological changes in living animals and forecast the outcome of experimental therapies in patients. Consequently, the market is slated to see strong growth over the forecast period due to both of these factors. Furthermore, the steady pace of technological innovation that leads to the production of hybrid imaging systems is primarily driving global market growth. Moreover, the number of clinical research organizations (CROs) and pharmaceutical firms is the use of in-vivo imaging systems in preclinical testing, which accelerates further the development of this market.<\/p>\n

Strict legislation in preclinical science, however, as well as high deployment and maintenance costs associated with preclinical imaging modalities impede market development over the poised period. In addition, the limitations imposed on animal testing due to laws implemented by organisations defending animal rights are the main factors impeding business development.<\/p>\n

Preclinical Imaging Market <\/strong>Segmental Analysis<\/strong><\/p>\n

The global preclinical imaging market has been analyzed based on the reagent, modality, and region.<\/p>\n

The modality-based segmentation of the market comprises into optical imaging systems, nuclear imaging systems, micro-ultrasound, micro-MRI, photoacoustic imaging, micro-CT, and magnetic particle imaging. The field of optical imaging systems is predicted to continue its dominance over the market share as it recorded in 2017.<\/p>\n

The reagent-based segmentation of the market comprises preclinical ultrasonic contrast agents, preclinical optical imaging reagents, preclinical MRI contrast agents, preclinical nuclear imaging reagents, and preclinical CT contrast agents. The field of preclinical optical imaging reagents is predicted to maintain its winning streak over the prognosis period.<\/p>\n

Preclinical Imaging Market <\/strong>Regional Overview<\/strong><\/p>\n

The Asia-Pacific preclinical imaging market<\/strong><\/a> is consists of developing economies like China, the Republic of Korea, India , Japan, Australia, and the rest of the Asia-Pacific region. The Asia-Pacific region is slated to be the region with the highest growth. the high demand for remote sensing services in various applications, such as precision farming, 3D terrain model building, damage evaluation, pipeline tracking, geohazard modeling, resource extraction, and security and intelligence is leading the Asia Pacific region market to secure the fastest CAGR.<\/p>\n

Driven by growing investments in numerous military and commercial satellite projects, North America is second to the European market in the demand for remote sensing satellites. The North American industry is powered primarily by an growing need for remote sensing services in diverse industries and the presence of major public and private companies.<\/p>\n

Europe is slated to hold the second-largest regional growth in the global market for preclinical imaging. The growing success of this region’s demand is resulting in further R&D investments towards the promotion of preclinical research. On the other hand, the Middle East & Africa is observing gradual growth and is slated to acquire for the lowest market share of the preclinical imaging market.<\/p>\n

Preclinical Imaging Market <\/strong>Competitive Dashboard<\/strong><\/p>\n

Some of the eminent players in the global preclinical imaging market are Bruker Corporation (US), MR Solutions (UK), PerkinElmer Inc. (US), Fujifilm Holdings Corporation (Japan), Milabs B.V. (The Netherlands), Mediso Ltd. (Hungary), LI-COR, Inc. (US), Miltenyi Biotec GmbH (Germany), Aspect Imaging (Israel), and Trifoil Imaging (US).<\/p>\n

Table Of Contents:
<\/strong><\/p>\n

Chapter 1. Report Prologue
<\/strong><\/p>\n

Chapter 2. Market Introduction
<\/strong><\/p>\n

2.1. Definition<\/p>\n

2.2. Scope Of The Study<\/p>\n

2.2.1. Research Objective<\/p>\n

2.2.2. Assumptions<\/p>\n

2.2.3. Limitations<\/p>\n

Chapter 3. Research Methodology
<\/strong><\/p>\n

3.1. Introduction<\/p>\n

3.2. Primary Research<\/p>\n

3.3. Secondary Research<\/p>\n

3.4. Market Reagent Estimation<\/p>\n

Chapter 4. Market Dynamics
<\/strong><\/p>\n

4.1. Drivers<\/p>\n

4.2. Restraints<\/p>\n

4.3. Opportunities<\/p>\n

4.4. Challenges<\/p>\n

Chapter 5. Market Factor Analysis<\/strong><\/p>\n

…TOC Continued<\/strong><\/p>\n

LIST OF TABLES<\/strong><\/p>\n

Table 1. Global Preclinical Imaging Market Synopsis, 2018–2023<\/p>\n

Table 2. Global Preclinical Imaging Market Estimates And Forecast, 2018–2023 (USD Million)<\/p>\n

Table 3. Global Preclinical Imaging Market, By Region, 2018–2023 (USD Million)<\/p>\n

Table 4. Global Preclinical Imaging Market, By Modality, 2018–2023 (USD Million)<\/p>\n

Table 5. Global Preclinical Imaging Market, By Reagent, 2018–2023 (USD Million)<\/p>\n

Table 6. North America: Preclinical Imaging Market, By Modality, 2018–2023 (USD Million)<\/p>\n

….Continued<\/strong><\/p>\n

LIST OF FIGURES<\/strong><\/p>\n

Figure 1. Research Process<\/p>\n

Figure 2. Segmentation For Global Preclinical Imaging Market<\/p>\n

Figure 3. Market Dynamics For Global Preclinical Imaging Market<\/p>\n

Figure 4. Global Preclinical Imaging Market Share, By Modality, 2017<\/p>\n

Figure 5. Global Preclinical Imaging Market Share, By Reagent, 2017<\/p>\n

Figure 6. Global Preclinical Imaging Market Share, By Region, 2017<\/p>\n

….Continued<\/strong><\/p>\n

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https:\/\/www.marketresearchfuture.com\/reports\/preclinical-imaging-market-7365<\/a><\/strong><\/p>\n

About Market Research Future:<\/strong><\/p>\n

At Market Research Future (MRFR)<\/strong>, we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.<\/p>\n

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.<\/p>\n

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.<\/p>\n

NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.<\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Market Research Future<\/a>
Contact Person:<\/strong> Abhishek Sawant
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9312
Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.marketresearchfuture.com\/reports\/preclinical-imaging-market-7365<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Preclinical Imaging Market Preclinical Imaging Market Research Report: by Product (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging System), by Reagent (Optical, Nuclear, CT Contrast Agents, MRI Contrast Agents) – Global Forecast Till 2023 Preclinical Imaging Market Scenario As per … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[435,406,411,403,404],"tags":[],"class_list":["post-502102","post","type-post","status-publish","format-standard","hentry","category-Europe","category-Pharmaceuticals-Biotech","category-Technology","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/502102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=502102"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/502102\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=502102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=502102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=502102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}